Malin Corporation plc (MLC) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases.
Total Cash From Operating Activities Chart for Malin Corporation plc
Malin Corporation plc (MLC) operating cash flow for FY2024 was EUR -1.3M. Malin Corporation plc's operating cash flow moved from EUR -17.0M in 2015 to EUR -1.3M in 2024 over 9 years.
Total Cash From Operating Activities (Euros)
R&D as % of Revenue
Key Stats
- Market Cap
- €30.28M
- Implied Share Price
- €7.00
- Enterprise Value
- -€31.82M
- Revenue (TTM)
- €41.00M
- EBITDA
- -€2.40M
- Profit Margin
- 0.00%
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- Price/Book (MRQ)
- 0.16
- Price/Sales (TTM)
- 6.18
- EV/EBITDA
- 186.08
- EV/Revenue
- 6.08
- Dividend Yield
- —
- Book Value
- €8.90
- Free Cash Flow (FY2024)
- -€1.30M
- Free Cash Flow Yield
- -4.29%
Snapshot as of 15th August 2026 — not point-in-time controlled, may lag the live market by a few days.